A001: Long-term 3D Histoculture of Mouse Whiskers Enable Confocal Imaging of Trafficking of Nestin-Expressing Multipotent Stem Cells

Jennifer Duong^1^, Sumiyuki Mii^1^, Fang Liu^3^, A.R. Moossa^2^, Robert M. Hoffman^1^,^2\*^

^1^AntiCancer Inc., 7917 Ostrow Street, San Diego,^2^Department of Surgery, University of California, San Diego, 200 West Arbor Dr., San Diego, CA,^3^Department of Anatomy, Second Military Medical University, Shanghai, China

We have previously demonstrated that nestin-expressing multipotent hair follicle stem cells are located above the hair follicle bulge and can differentiate into neurons and other cell types *in vitro* (Proc. Natl. Acad. Sci. USA 100, 9958-9961, 2003; Proc. Natl. Acad. Sci. USA 102, 5530-5534, 2005). The nestin-expressing hair follicle stem cells promoted the recovery of pre-existing axons when they were transplanted to the severed sciatic nerve or spinal cord (Proc. Natl. Acad. Sci. USA 102, 17734-17738, 2005; Cell Cycle 7, 1865-1869, 2008). We have also previously demonstrated that the whisker hair follicle contains nestin-expressing stem cells in the dermal papilla (DP) as well as in the bulge area (BA) (Cell Cycle 10:830-839, 2011), but that their origin is in the BA (J. Cell. Biochem. 112, 2046-2050, 2011). In the present study, we established the technique of long-term Gelfoam^®^ histoculture of whiskers isolated from transgenic mice in which nestin drives green fluorescent protein (ND-GFP). Confocal imaging was used to monitor ND-GFP-expressing stem cell trafficking in real time between the BA and DP to determine the fate of the stem cells. It was observed over a two-week period that the stem cells trafficked from the BA toward the DP area and extensively grew out onto Gelfoam^®^ forming nerve-like structures. This new method of long histoculture of whiskers from ND-GFP mice will enable the extensive study of the behavior of nestin-expressing multipotent stem cells of the hair follicle.

A002: Repeated Microneedle Stimulation Induce the Enhanced Expression of Hair-Growth-Related Genes

Kwanho Jeong^\*^, Ye Jin Lee, Jung Eun Kim, Young Min Park, Beom Joon Kim^1^, Hoon Kang

Department of Dermatology, College of Medicine, The Catholic University of Korea, ^1^Chung-Ang University College of Medicine, Seoul, Korea

Skin wound healing is biologically stepwise systemized process which involves cross reactions between different cutaneous cell constituents. Recently, it is known that cutaneous injury with microneedle produces new collagen formation and helps cellular revitalization. We designed experiment to know what will happen after repeated small injury to the hairy skin area. Disk-type microneedle roller was used to evaluate the differences of hair growing effects according to microneedle length and rolling cycles. In addition, the change of hair-growth-related factors was checked. 10 mice (C57BL/6 female; 8 week of age) were divided into 5 groups and each group dorsal skin was depilated. Disk-type roller was applied to each group during 4 weeks (5 times a week) according to microneedle length such as 0.15 mm, 0.25 mm, 0.5 mm, 1.0 mm. After obtained microneedle length for hair growing, most effective rolling cycle determining experiment was carried out such as 3, 6, 10, 13 cycles. Hair growing after microneedle stimulation was evaluated with photograph and handheld digital microscope. To examine hair follicles status and its related growth factors, specimens were obtained by excision biopsy from the dorsal aspect of each mouse. Tissue samples were utilized for the immunohistochemistry and RT-PCR study. 0.5 mm microneedle and 6, 10 rolling cycles showed most valuable hair growing effect. VEGF, β-catenin, Wnt3a, and Wnt10b were strongly stained, increased in the 0.5 mm microneedle and 10 rolling cycle samples and their gene expression was remarkable in the RT-PCR.

This study was supported by a National Research Foundation of Korea grant funded by the Korean government (2011-0008687)

A003: Blocking K

atp

Channels Inhibits Hair Growth, Promotes Catagen-Like Changes and Alters Paracrine Signaling in Scalp Hair Follicles

Heero Rahman, Nilofer Farjo, Bassam Farjo, Valerie Randall

Centre for Skin Sciences, University of Bradford, Bradford, UK and Farjo Medical Centre, Manchester, UK

Minoxidil, an ATP-sensitive K~ATP~ channel opener, a well-known treatment for alopecia, can open SUR2 K~ATP~ channels. Human hair follicles contain two forms of K~ATP~ channels, SUR1 and SUR2B (Shorter et\~sal., 2008). To confirm the importance of K~ATP~ channels in human hair growth, we investigated the effect of tolbutamide, a K~ATP~ channel blocker, which can inhibit both SUR1 and SUR2B channels. Scalp follicles were microdissected and cultured with, or without, tolbutamide (10 nM-1 mM) for 9 days with daily observation and measurement. Also after 4 days incubation with 1 mM tolbutamide; total RNA (3 pooled samples, each from 5 different individuals) was extracted, quality and quantity checked before differences in gene expression were determined using DNA microarray analysis; quantitative real-time PCR (qPCR) confirmed differences. Tolbutamide significantly inhibited hair follicle growth at concentrations which would block SUR1 alone (100 nM) or both channels (1 mM). At 1 mM, tolbutamide significantly increased the gene expression of both TNF (*P*\<0.05) and its receptor, TNFRSF1A (*P*\<0.01) and caused visible catagen-like changes, confirmed by histology. Therefore, blocking both the minoxidil-sensitive SUR2B and minoxidil-insensitive SUR1, K~ATP~ channels can inhibit human hair growth in organ culture, promote catagen-like changes and the inhibitory paracrine signaling system of TNF/TNFRSF1A involved in catagen development. This is strong new evidence for a biological role for follicular K~ATP~ channels in hair growth. Further investigations of the roles of K~ATP~ channels in human hair follicles should enable the development of better treatments for both hair loss and excessive hair conditions.

A004: Dickkopf 1 Promotes Regression of Hair Follicles

Mi Hee Kwack\*, Moon Kyu Kim, Jung Chul Kim, Young Kwan Sung

Department of Immunology, School of Medicine, Kyungpook National University, Daegu, Korea

Recently, we suggested that Dickkopf 1 (DKK-1) is a pathogenic mediator involved in male pattern baldness. As premature catagen onset is a key characteristic of male pattern baldness, in this study, we evaluated if DKK-1 plays a role as a catagen inducer in hair cycling. Herein we report that recombinant human DKK-1 (rhDKK-1) injection into the hypodermis of mice during anagen caused premature onset of catagen, whereas neutralizing DKK-1 antibody delayed anagen-to-catagen transition in mice. Also, treatment with rhDKK-1 led to a decrease in final hair follicle length, whereas DKK-1 antibody led to an increase compared with control animals. In addition, DKK-1 and DKK-1 messenger RNA expression is most upregulated in follicular keratinocytes of late anagen in depilation-induced hair cycle progression. Moreover, we observed that rhDKK-1 blocks canonical Wnt-mediated activation of β-catenin signaling and induces the proapoptotic protein Bax, resulting in apoptosis in outer root sheath (ORS) keratinocytes. Taken together, our data strongly suggest that DKK-1 is involved in anagen-to-catagen transition in the hair cycle by regulating the activity of follicular keratinocytes.

A006: Hair Follicle Nestin-Expressing Stem Cells Form Nerves in 3D Histoculture of Mouse Whiskers

Sumiyuki Mii^1,2,3^, Jennifer Duong^1^, Fang Liu^4^, Yasuyuki Amoh^3^, Norimitsu Saito^3^, Kensei Katsuoka^3^, A.R. Moossa^2^, Robert M. Hoffman^1,2^

^1^Anti Cancer Inc, San Diego, ^2^Department of Surgery, University of California, San Diego, CA, ^3^Department of Dermatology, Kitasato University School of Medicine, Kanagawa, Japan, ^4^Department of Anatomy, Second Military Medical University, Shanghai, China

We have previously discovered nestin-expressing multipotent hair-follicle-stem cells (Proc. Natl. Acad. Sci. USA 100, 9958-9961, 2003; Cancer Res. 65, 2337-2343. 2005; Cancer Res. 65, 5352-5357, 2005; Cell Cycle 7, 1865-1869, 2008). Mouse vibrissa (whisker) hair follicles were obtained from transgenic mice, in which the nestin promoter drives the expression of green fluorescent protein (ND-GFP). The whisker follicles contain nestin-expressing stem cells which originate from the follicle bulge. The whiskers were placed in long-term 3-D histoculture on Gelfoam^®^ and imaged with confocal microscopy. Nestin-GFP expressing cells were observed to traffic from the bulge area (BA) of the histocultured whisker and proliferated at the cut end of the severed nerve to extend the nerve which contained nestin-expressing spindle-shaped cells that co-expressed β3-tubulin as well as nestin-negative round cells that expressed GFAP. In subsequent experiments, whisker follicles with a growing sensory nerve, expressing ND-GFP, were co-cultured on Gelfoam^®^ with the trigeminal nerve derived from mice expressing red fluorescent protein (RFP). Whiskers with a growing ND-GFP expressing nerve were placed in Gelfoam^®^ culture next to the trigeminal nerve expressing RFP. On day 6 of Gelfoam^®^ culture, dual-color fluorescence confocal imaging showed that the whisker-follicle sensory nerve grew out and fused with the trigeminal nerve. Our results suggest that a major function of the nestin-expressing stem cells in the hair follicle may be formation of the hair follicle sensory nerve which can then fuse with the trigeminal nerve, which may mimic the *in vivo* sensory circuit. Gelfoam^®^ histoculture is a very powerful method to study stem cell behavior of the hair follicle including nerve formation and the development of a sensory circuit.

A007: Hair Follicle Regeneration in Mice After Wounding by Microneedle Roller

Beom Joon Kim\*, Yun Young Lim, Hyeong Mi Kim, Yang Won Lee^1^, Chong Hyun Won^2^, Chang Hun Huh^3^, Hoon Kang^4^

Department of Dermatology, Chung-Ang University, ^1^Konkuk University, College of Medicine, ^2^Asan Medical Center, University of Ulsan College of Medicine, Seoul, ^3^Seoul National University Bundang Hospital, Seongnam, Gyeonggi, ^4^College of Medicine, The Catholic University of Korea, Seoul, Korea

Microneedle is an efficient device for facilitating drug delivery through the stratum corneum. During microneedle rolling, various growth factors including human platelet derived growth factor (PDGF) and epidermal growth factor (EGF) were increased through platelet activation and skin wound regeneration mechanism. We investigated the effect of microneedle roller stimulation on activating the hair growth pathway. The preclinical test was performed using microneedle rollers with 0.25 mm or 0.5 mm in needle size. Mice were divided into seven groups: negative control group, positive control group (50% ethanol), 3% minoxidil group, horizontal wound group, vertical wound group, 0.25-mm-sized microneedle roller group, and 0.5-mm-sized microneedle roller group. Microneedle roller treated groups showed earlier and faster hair growth than untreated mice group. And the hair induced by microneedle roller was shinier than the hair induced by minoxidil. Increased expression of hair follicle growth related molecules in microneedle roller treated group was also confirmed by immunoblotting and RT-PCR. These findings suggest that microneedle roller would be useful to treat hair loss refractory to minoxidil treatment. This study was supported by a National Research Foundation of Korea grant funded by the Korean government (2011-0008687).

A008: Evidences of Hypersensitivity in Early Phase of Alopecia Areata: A Retrospective Analysis of 741 Patients

Ying Zhao, Xiaoting Zhang, Yugang Gong, Yanting Ye, Zeming Cai, Bin Zhang, Sillani Caulloo, Jian Yang, Wenna Chen, Xingqi Zhang

Department of Dermatovenereology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China

**Objective:** To investigate the underlying factors affecting onset of alopecia areata (AA) by analysis of clinical, laboratory, dermoscopic and histopathologic difference between early and late phases of AA. **Methods:** Detailed clinical data were collected from 741 AA patients. Among them, 417 had laboratory blood tests including full blood count, thyroid function test, autoimmune antibodies as well as serum IgE level done. Scalp dermoscopy and biopsy were performed in part of the patients. Infiltration cells counts were done from five fields of view at high power magnification. Patients were divided to early phase (≤ 3 months) and late phase (\> 3 months) according to the duration. **Results:** The study group comprised of 379 males and 362 females, mean age of 28.9 years and age range from 2 months-76 years. In comparison to late phase (440 cases), AA patients in early phase (331 cases) showed lower incidence of nail aberrations (*P*\<0.001), less hair loss area (*P*\<0.001), higher incidence of gentle hair-pull test (*P*\<0.001), as well as more chance to have a serum IgE level higher than normal (*P*=0.003). Among all the dermoscopic signs, only incidence of black dots in early phase of AA patients was higher than late phase (*P*\<0.001). The eosinophilic infiltration in early phase of AA patients was more intense, while mononuclear infiltration was less intense, and lesional terminal/vellus ratio was higher than late phase (*P*=0.035, \<0.001, 0.006). **Conclusion:** Early phase of AA patients were featured by higher serum IgE level and more intense lesional eosinophilic infiltration. We proposed that hypersensitivity may play a role in the onset of alopecia areata.

A009: Characterization of Hair Follicle Immune Privilege and the Potential Contribution of Somatostatin

Trisia Breitkopf, Blanche KK Lo, Gigi Leung, Eddy Wang, Mei Yu, Jerry Shapiro, Kevin J McElwee

Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada

Immune privilege (IP) is believed to exist in the anagen hair follicle (HF). We wanted to further examine IP in HFs to elucidate a functional mechanism. Normal human HFs were microdissected into the lower third, including the bulb, and the remaining dermal and root sheaths for investigation relative to nonfollicular epidermis. Peripheral blood mononuclear cells (PBMC) were cultured with histoincompatible primary epidermal cells or HF bulb or root sheath cells. ELISA showed that allogeneic HF bulb and sheath cells induced significantly less IFN-γ secretion (18.4 and 9.8 pg/ml, respectively) from PBMCs than epidermal cells (35.3 pg/ml). We screened expression of 40+ IP-related genes by quantitative RT-PCR in HF bulb and sheath samples (*n*= 5) relative to interfollicular epidermal samples (*n*=10). Most notably, somatostatin (SST) was significantly upregulated in the bulb and sheaths. Further examination showed strong SST staining in HF outer root sheath compared to epidermis and significantly greater SST secretion from HF sheath than epidermal cell culture. PBMCs were cultured with allogeneic epidermal cells and SST, analyzing supernatant for IFN-γ to determine SST effect. SST significantly inhibited PBMC IFN-γ secretion. Two different methods of SST antagonism in PBMC and allogeneic sheath cell co-culture led to significantly higher IFN-γ secretion. We reveal a novel finding that SST is expressed in normal human HFs. Blocking SST in cell culture can interfere with HF sheath IP. We propose that SST may have an IP role in the HF. This could have implications for treatments of inflammatory hair loss diseases or for tissue transplantation.

A010: The Human Hair Follicle Cycle: A Guide

Jennifer. E. Kloepper^1^\*, Dorothee Langan^1^, David A. Whiting^2^, Koji Sugawara^1,3^, Nadine Doerwald^1^, Christian Rose^1^, George Cotsarelis^4^, Ralf Paus^1,5^

^1^Department of Dermatology, University of Luebeck, Luebeck, Germany, ^2^Baylor Hair Research and Treatment Centre, University of Texas, Southwestern Medical Centre, Dallas, Texas, USA, ^3^Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan, ^4^Kligman Laboratories, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA, ^5^School of Translational Medicine, University of Manchester, Manchester, UK

Hair follicles (HFs) undergo life-long cyclic transformations between stages of rapid growth (anagen), apoptosis-driven regression (catagen) and relative quiescence (telogen). Since disturbances of this HF cycling underlie essentially all of the most common hair growth disorders, it is clinically important to be able to recognize and classify, on the basis of well-defined morphological criteria, individual hair cycle stages in human skin biopsies.

While guidelines for the accurate classification of the murine hair cycle exist, a satisfactory manual remains to be developed for human HF cycling. Here, we provide a simple, comprehensive and pragmatic guide that is based on simple histochemical and immunohistological analyses. Distinguishing between vellus and terminal HFs, we suggest basic and auxiliary criteria for recognizing key hair cycle stages and illustrate these stages by schematic drawings and representative micrographs that facilitate stage recognition even by beginners. The suggested auxiliary criteria/markers include analyses of Ki-67+ or TUNEL+ cells in defined HF compartments. In addition, we show how a hair cycle stage can still be identified even if key HF structures are only partially visible. This is complemented by an illustrated glossary of frequently employed (and often confused) HF anatomy terms. Our guide serves as a basis for standardized human hair cycle analysis.

A011: Mammalian Target of Rapamycin Complex 1 (Mtor1) May Modulate the Timing of Anagen Entry

Antonia Kellenberger^1,3^, Miyuki Tauchi^1,2,3^

^1^Division of Molecular Neurology and ^2^Department of Neurology, University Hospital Erlangen; ^3^Institute of Anatomy II, University of Erlangen-Nuremberg, Erlangen, Germany

Mammalian target of rapamycin (mTOR) is a central regulator of cell proliferation and survival by integrating energy and nutrients information. Hair follicles undergo cycles of quiescence (telogen), growth (anagen), and regression (catagen), which are tightly regulated. mTOR is a direct target of Wnt and IGF-1 pathways, which promote hair growth. mTOR may interact with Akt-related molecules that mediate Wnt signaling and control hair follicle proliferation. Furthermore, activated mTOR has been readily demonstrated in telogen hair follicles and mTOR is involved in hair follicle tumor formation. These facts suggest that mTOR participates in the hair cycle regulation but there is limited direct evidence that mTOR may regulate hair follicle. Thus, we sought to investigate whether mTOR complex 1 (mTORC1) regulates hair growth cycle using immunohistochemical, biochemical, and functional approaches *in vivo*. We found that phosphorylated mTOR at S2448 (p-mTOR) was localized to specific sites in hair follicles in a phase-dependent manner. The localization of p-mTOR was indicative for its role in hair growth initiation. Moreover, quantitative analysis of mTOR kinase activity specific to mTORC1 downstream molecule confirmed growth phase-dependent changes. *In vivo* pharmacological challenge using a specific mTORC1 inhibitor, rapamycin, delayed hair cycle initiation, suggesting a functional relevance of mTORC1 in anagen entry. Based on our findings, we propose that mTORC1 may participate in the hair cycle regulation at the timing decision of anagen initiation

A012: Conventional Grading Classifications or Dermatoscopy For Early Diagnosis of Female Pattern Hair Loss?

Sukesh M.S\*, Rachita Dhurat

Department of Dermatology, L.T.M Medical College and General Hospital, Sion, Mumbai, India

**Introduction**: Androgenetic alopecia (AGA) in males is patterned and therefore easy to recognize. However, FPHL in females, usually presents with diffuse thinning over the crown (widening of the partition). A clinical diagnosis based on Conventional Ludwig/Sinclair classification may underestimate early FPHL as FPHL could be a diffuse process, which may present without patterned hair loss. Hair Diameter Diversity (HDD) \> 20% provides a valuable tool in accessing the miniaturization process, characteristic of FPHL. **Aims:** To document apparent sparseness of hair and HDD on dermatoscopy (20Χ), separately at standard sites over scalp and to assess whether conventional classification or dermatoscopy is useful for early diagnosis of FPHL. **Methodology:** 40 Indian females complaining of increased shedding of hair of more than 6 months duration with reduction in volume of hair with or without evidence of thinning over crown were enrolled. Clinical sparseness and HDD on dermatoscopy were assessed separately at midscalp \[MS\], bi-frontal (BF), temporal (T) and occipital (O) areas at specific sites. HHD \>20% at the above sites were considered to be a diagnostic sign of FPHL. **Results:** Dermatoscopy was more useful to pick up early FPHL than Conventional Grading system. Dermatoscopy was also useful to evaluate the androgenetic process in other areas where apparent sparseness was not evident ([Table 1](#T1){ref-type="table"}). **Conclusion:** FPHL can be unpatterned and dermatoscopy serves as a diagnostic tool for early non-patterned FPHL. It should be offered as a routine diagnostic procedure and the entire scalp has to be assessed for miniaturization, in patients presenting with hair loss; especially females with chronic hair shedding without apparent thinning, where a clinical diagnosis of FPHL is not possible.

###### 

(A012):- Hair diameter diversity
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A013: Discovering Messenger RNA and Micro RNA Expression Patterns in Normal, Graying Hair

Rita Araújo^1,2^, Teresa Matamá^1,2^, Ana Preto,

Artur Cavaco-Paulo^2^, Andreia Gomes^1\*^

^1^CBMA--Centre of Molecular and Environmental Biology, University of Minho, Campus Gualtar, Braga,^2^Department of Textile Engineering, University of Minho, Campus Azurém, Guimarães, Portugal

Graying is part of normal, physiological aging of hair, but it strongly affects individuals, psychological and socially, fuelling a multi-million dollar industry. This work aims at making a significant contribution to the elucidation of signaling pathways involved in the regulation of hair morphogenesis and melanogenesis. By combining microarray profiling of gene expression and microRNAs it will be possible to establish regulatory networks active during hair aging and graying. Determining the role of microRNAs in human hair follicle biology will provide important and novel insights into the regulation of these physiological processes, creating possibilities to modulate them.

Gray and pigmented hair follicles were plucked from each of five male donors under 40s without balding for total RNA and microRNA extractions.

According to the analysis done, there is a group of genes involved in pigmentation which showed the highest expression fold changes between gray and pigmented hair among 108 transcripts expressed with a minimum fold change of 1.2 up or down (unadjusted P-value 0.05). The expression pattern of the most variable genes was confirmed by real-time PCR. Among the 381 microRNA analyzed, a qualitative analysis identified 17 microRNA that are least expressed in gray hair follicles and 5 microRNA with the opposite trend.

The data obtained so far suggests an important epigenetic regulation by regulatory RNAs. While microarray profiling of mRNA identified a panel of known genes, mostly related to melanogenesis, strongly modulated during normal hair graying, the microRNA profiling showed distinct expression patterns between pigmented and gray hair follicles.

A014: Tamoxifen Speeds up Melanin Extrusion in Normal Human Melanocytes

Teresa Matamá^1,2^, Rita Araújo^1,2^, Ana Preto^2^, Andreia Gomes^2^ e Artur Cavaco-Paulo^1\*^

^1^Department of Textile Engineering, University of Minho, Campus Azurém, Guimarães,^2^Department of Biology, CBMA (Centre of Molecular and Environmental Biology), University of Minho, Campus Gualtar, Braga, Portugal

Physical appearance has significant importance psychologically and socially, with hair occupying a prime position. A growing search for effective ingredients that modulate melanin synthesis is evident in scientific literature. Tamoxifen was described in medical case reports of occasionally causing gray hair repigmentation and localized skin hyperpigmentation. This work aims to confirm, *in vitro*, the effect in melanogenesis of tamoxifen and 4-hydroxy-tamoxifen, one of its most bioactive derivatives.

Epidermal melanocytes are a good cell model to study melanogenesis, allowing the dissection of molecular pathways involved in melanogenesis. Normal Human Adult Melanocytes (NHEMs) were treated with physiological concentrations of tamoxifen and 4HO-tamoxifen during 72 hours. Cytotoxicity was evaluated by lactate dehydrogenase leakage. Total melanin was quantified optically and cyclic adenosine monophosphate (cAMP) was determined by competitive ELISA. The relative mRNA levels of several genes involved in melanogenesis were also investigated by real-time PCR.

Under the conditions used, tamoxifen and 4HO-tamoxifen treatments, not toxic to NHEM, induced a significant time effect on the amount of melanin released to the culture medium, although not in the total amount produced after 72 h. cAMP, a major second messenger in signaling pathways important in melanogenesis, was not affected by the treatment. The transcript levels of CAT, SILV and MLANA, encoded by genes directly related with skin and hair pigmentation, showed a trend to increase upon these treatments.

According to the results, even in such a short treatment period, tamoxifen and 4HO-tamoxifen promoted melanin extrusion and these compounds seem to act as melanogenesis stimulators at a molecular level.

A015: An Unusual Occurrence of Regrowth of Black Hairs in Two Red-haired Alopecia Areata Patients

Yuval Ramot\*, Rodney D. Sinclair^1^ and Abraham Zlotogorski

Department of Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, ^1^Department of Medicine (Dermatology), University of Melbourne, Fitzroy, Australia

Alopecia areata (AA) is a very common dermatologic disease, which has a strong predilection to affect only dark pigmented hair, with characteristic sparing of gray/white hairs. In line with this observation, AA affecting red-haired individuals is considered a strikingly rare phenomenon. Additionally, during initial hair regrowth, the first hairs to grow may frequently show pigment alterations, ranging from total achromia to mild hypopigmentation. We report two cases of red-haired males who were afflicted with patch-type AA. Astonishingly, the regrowing hairs were black-colored, in contrast to the surrounding red hairs. To the best of our knowledge, this is the first report of red-haired patients with AA, and also one of the rare cases of hair color change from red to black. It is unknown why AA is so rare in red-haired individuals, but evidence is accumulating that pigmentation and melanocytes might play an important role in AA pathogenesis. The recent findings that the melanocortin-1 receptor gene, which is associated with the red hair phenotype, is also involved in immunological and inflammatory processes, might suggest a pivotal role for this gene in AA pathogenesis. Better understanding of the role of pigmentation in AA pathogenesis might lead to new treatment modalities for AA patients.

A016: Epigenetic Mechanisms of Melanocyte-Specific Gene Expression

T.Y. Sharova^1^, M. Gdula^1,2^, K Poterlowicz^2^, M.Y. Fessing^2^, A.A. Sharov^1^

^1^Department of Dermatology, Boston University School of Medicine, Boston, MA, ^2^Centre for Skin Sciences, School of Life Sciences, University of Bradford, UK

The mammalian nucleus is a complex and highly organized organelle that allows cells differentiation and effectively fulfil their functions. Higher-order chromatin structure and nuclear compartmentalization of transcriptionally active and inactive domains and transcription machinery play an important role in regulation of gene expression and can be altered in diseases. Melanocytes are highly specialized pigment-producing cells, playing distinct function in the skin controlled by the cell-type specific gene expression programs. In human hair follicle, several subpopulations of melanocytes were identified based on the pigment-production activity. By three-dimensional fluorescence in situ hybridization (3D-FISH) and confocal microscopy, we show that in pigment producing melanocytes located in the hair bulb, intra-nuclear positioning of the DNA loci containing melanocyte-specific genes tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1) differ very substantially, compared to the amelanotic melanocytes of the outer root sheath. Analysis of the radial distributions in the nuclear space and intra-chromosomal positioning of the gene loci showed that TYR and TYRP1 were occupied in much more interior position in pigment producing cells, compared to amelanotic cells. Furthermore, analysis of nascent and mature RNA transcripts of TYR and TYRP1 genes also showed the distinct spatial and temporal organization of the transcriptionally active and inactive pigment gene loci in distinct populations of the hair follicle melanocytes depicted by RNA-FISH. These data demonstrate for the first time a distinct intra-nuclear organization and activity of the pigment-specific gene loci in melanotic and amelanotic melanocytes within human hair follicle.

A017: Microscopic Examination of Hair and Eyebrows may Help in the Diagnostic of Kabuki Syndrome

Déborah Salik, Jean-Jacques Stene^1^, Alina Ferster^2^, ^3^Chantal Dangoisse

Department of Dermatology, ^2^Department of Hemato-oncology, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles (ULB), ^1^Department of Dermatology, CHU Saint-Pierre, Université Libre de Bruxelles, Belgium

Kabuki syndrome (Niikawa-Kuroki syndrome) is a multiple congenital abnormalities/mental retardation syndrome due to a mutation in the MLL2 gene. The diagnostic is based on clinical findings: typical facial dysmorphism, skeletal anomalies, growth deficiency, developmental retardation and dermatoglyphic abnormalities. Ectodermal abnormalities may be associated, such as trichorrhexis nodosa.

We report the case of a 5-year-old boy with a suspected Kabuki syndrome with unusual hematologic features.

At birth, facial dysmorphism, depigmented macules of the trunk, hypoplastic nails and hypotonia were reported. During the two first years, he presented feeding problems, psychomotor development retardation, recurrent pneumococcal infections and auto-immune hemolytic anemia, which resolved thereafter. Cytogenetic was normal. A primary immunodeficiency and/or auto-immune lymphoproliferative syndrome were disclosed.

At the age of two, the first microscopic examination of sparse woolly hair in frontotemporal area revealed trichorrhexis nodosa, but a second examination two years afterwards was negative.

At 5 years, microscopic examination of hair was still negative but the eyebrows showed trichorrhexis nodosa. Clinical examination revealed microcephaly, long palpebral fissures with a palpebral ptosis, large low implanted ears, hypodontia and a vitiligo patch in the hair as well as brachydactyly of V, hypoplastic ribs and unspecific skeletal abnormalities of the long bones. Unexplained marrow failure developed.

Based on microscopic hair and eyebrows examinations and clinical features, it might be suggested that the ectodermal abnormalities, especially trichorrhexis nodosa, could be part of the spectrum of Kabuki syndrome.

A018: Straight Hair Nevus. A new case?

Antonio Guilabert

Clínica Dermatológica DERMAS, Barcelona, Spain.

*Straight hair nevus* (SHN) is the inverse picture of woolly hair nevus. There are few cases of SHN in the literature associated with epidermal nevus or ichthyosis.

We present the case of a 8-year-old girl with past history of multiple pilomatrixomas, who presented with straight and thin hairs over a yellow and smooth scalp surrounded by normal hair over normal scalp. The biopsy of the affected area was consistent with early nevus sebaceus. The study of the two populations of hair by means of optic and electronic microscopy and X-ray microanalysis showed no abnormalities.

The affected hairs in our case, in the line of other reports, appeared over a nevus sebaceus. It is plausible to speculate that the deep changes in the skin may lead to hairs with different morphology, or, on the other hand, either population of hairs represent different clones with different hair and skin expression.

A019: Investigation of Variants of Diverse Hormone Receptor Genes and the Male Pattern Baldness Major Genetic Susceptibility Loci

AR/EDA2R

and 20p11 in Women with Female Pattern Hair Loss

Silke Redler^1\*^, Rachid Tazi-Ahnini^2^, Maggie P. Birch^3^, Karin Dobson^3^, Felix F. Brockschmidt^1,4^, Dmitriy Drichel^5,6^, Kathrin A. Giehl^7^, Nadine Kluck^1,4^, Roland Kruse^8^, Gerhard Lutz^9^, Hans Wolff^7^, Tim Becker^5,6^, Markus Böhm^10^, Markus M. Nöthen^1,4^, Andrew G. Messenger^3^, Regina C. Betz^1^

^1^Institute of Human Genetics, University of Bonn, Bonn, Germany, ^2^Department of Infection and Immunity, University of Sheffield, Sheffield, UK,^3^Department of Dermatology, Royal Hallamshire Hospital, Sheffield, UK, ^4^Department of Genomics, Life & Brain Center, University of Bonn,^5^German Center for Neurodegenerative Diseases (DZNE), ^6^Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn,^7^Department of Dermatology, University of Munich, Munich,^8^Dermatological Practice, Paderborn, ^9^Dermatological practice, Hair & Nail, Wesseling, Germany, ^10^Department of Dermatology, University of Münster, Münster, Germany

Androgenetic alopecia is a common hair loss disorder which occurs in both sexes. The disorder is termed male-pattern baldness (AGA) in men, and female pattern hair loss (FPHL) in women. Although the precise etiopathogenesis of FPHL remains unknown, one likely hypothesis is that sex steroid hormones are crucial for the development of FPHL. However, we could not demonstrate significant association for any of the 32 genotyped variants of the hormone receptor genes aromatase-gene (CYP19A1), progesterone receptor (*PGR*), steroid-5-alpha-reductase alpha polypeptide 1 and 2 (*SRD5A1, SRD5A2*) and estrogen receptors 1 and 2 (*ESR1, ESR2*). Another likely hypothesis is that FPHL and AGA share common disease-causing mechanisms and a common genetic background. The two major susceptibility loci for AGA are the X-chromosomal locus AR/EDA2R; and a locus on chromosome 20p11. We performed a fine mapping study of AR/EDA2R and genotyped five SNPs from the chromosome 20p11 region that reached genome-wide significance in a recent GWAS of AGA. No significant association was obtained for any of the 20p11 variants, assuming that this locus do not influence susceptibility to FPHL. At *AR/EDA2R*, seven markers showed significant association in the subgroup of early affected UK patients, suggesting that the *AR/EDA2R* locus may be specifically involved in the pathogenesis of early-onset FPHL. Enlargement of the collective of 230 patients (145 UK; 85 German) and 329 controls (179 UK; 150 German) as well as a genome-wide association study might help to understand the role of *AR/EDA2R* and to identify further genes contributing to the development of FPHL.

A020: Microarray-Based Identification of Novel Genes Involved in Human Female Hair Aging

Konrad Kleszczynski, Remo Gräub^1^, Nathalie Kruse, Detlef Zillikens, Tobias W. Fischer

Department of Dermatology, Allergology and Venereology, University of Lübeck, Lübeck, Germany,^1^DSM Nutritional Products, Personal Care, Basel, Switzerland

Aging of hair is quite unaddressed in dermatological research and diffuse hair loss, often occurring in women of mid/higher age, is only a symptom-based diagnosis. Therefore, a systematic search for causative mechanisms was performed.

Hair follicles from female scalp skin biopsies (*n*=24) were subjected to microarray analysis. Volunteers were non-smokers allocated to three groups: i) 20-25 y, no hair loss, pre-menopausal, ii) 40-45 y, diffuse hair loss, pre-menopausal, iii) 60-65 y, diffuse hair loss, post-menopausal. A fourth group was recruited with 20-25 y as well, but with smoking habits to compare smoke-induced with age-induced oxidative stress.

Single-gene analysis identified age-dependent significantly regulated genes related to neuronal stress, inflammation, innate immune response and endocrinology. Additional pathway analysis identified oxidative stress, collagen, transporter channels and cell cycle as further relevant biological processes. A two-fold unidirectional significant (*P*\<0.05) regulation was found in 163 genes comparing 20-25 y vs. 60-65 y, and in 68 genes comparing 20-25 y vs. 40-45 y. The smoker group revealed 130 regulated genes compared to the non-smoker group (20-25 y). Using the iHOP search tool combined with PubMed, 111 genes of high interest were identified. A selection of these genes was confirmed by real-time PCR, and in situ detection and localization of their respective proteins was confirmed by immunofluorescence microscopy.

These data strongly suggest that hair aging is paralleled by regulation of specific genes and pathways related to essential hair biology processes, suggesting that they might be causative for hair loss in women after the age of 40.

A021: Effect of Lexington HairMax LaserCombÒ on Males and Females with Androgenetic Alopecia

Jimenez JJ

Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida

Androgenetic alopecia (AGA) is a common chronic dermatologic disorder affecting both men and women. Due to its frequency of 50% in men and 40% in women by age 50, there has long been a search for efficacious management. Current conventional therapy relies on minoxidil and finasteride; however, some patients are not responsive to them. The Hairmax LaserComb^®^ is an FDA-cleared device to treat AGA, thereby providing another avenue for treatment. The LaserComb delivers low intensity visible red (655-nm ±5%) laser light to the scalp. A previous clinical study demonstrated that LaserComb treatment resulted in hair regrowth and hair maintenance in male patients with AGA. We therefore tested whether the LaserComb^®^ would have the same consistent and predictable effect on females with AGA. To this effect, we conducted independent, randomized, double-blind, sham device-controlled, multicenter studies in men and women using various models of the HairMax LaserComb^®^ . All subjects received 655-nm (±5%) laser from the LaserComb or light from white LED bulbs (sham device), to the scalp, and all areas of the scalp were treated for the same duration. After 26 weeks of treatment, among the 103 male and 122 female subjects who completed the study, terminal hair count at target sites showed significant improvement of hair growth and density in laser-treated group compared to the sham group. These results not only underscore the results previously obtained in men with AGA, but also provides strong evidence that the LaserComb is an effective option for treating women with AGA.

A022: Association of Androgenetic Alopecia with Obesity, Hemoglobin A1c, Low-Density Lipoprotein Cholesterol, Alanine Transaminase, Gamma-Glutamyl Transpeptidase and Systolic Blood Pressure: A Clinic-Based Survey in Japan

Taro Koyama, Kazuhiro Kobayashi, Nagaoki Wakisaka, Nobuo Hirayama, Sawako Konishi, Satoko Hamanaka, Yasutaka Fukuda, Nobutaka Usui, Eriko Nakano, Ryo Nagasaka, Yoshihiro Yasuda, Yushi Moriya, Yoshio Nakamizo, Katsuyuki Takeda, Masaya Kawakami

**Introduction:** Hypertension, dyslipidemia, and insulin resistance have been reported to be associated with androgenetic alopecia (AGA). However the results of studies show inconsistent results. **Methods:** A clinic-based cross-sectional survey was conducted in Japan. The total of subjects was 2664 men aged 16-72 years. After exclusion of subjects with incomplete data, 1873 men were analyzed with multivariate logistic regression to assess the association between AGA evaluated by modified Hamilton-Norwood classification (\* I-III vs IV-VII, , \*\* I-III vs IIIv-VII, \*\*\* I-IIIv vs IV-VII) and various characteristics, such as, family history of hair loss, smoking history, alcohol intake, hemoglobin A1c (HbA1c), blood pressure, body mass index (BMI), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, uric acid and liver function including alanine transaminase (ALT), aspartate amino transferase and gamma-glutamyl transpeptidase (gamma-GTP). **Results:** Statistically significant associations (*P*\<0.05) were found between AGA and the following factors with multivariate logistic regression: age (10-year increase) \[odds ratio (OR) 2.759\*, 2.145\*\*, 2.012\*\*\*, 95% confidence interval (CI) 2.343-3.248\*, 1.855-2.481\*\*, 1.799-2.249\*\*\*\], father hair loss \[OR 1.473\*, 1.364\*\*, 1.344\*\*\*/ 95% CI 1.138-1.907\*, 1.090-1.707\*\*, 1.100-1.643\*\*\*\], BMI 25+ \[OR 2.566\*, 2.031\*\*, 1.950\*\*\*/ 95% CI 1.709-3.854\*, 1.390-2.968\*\*, 1.478-2.578\*\*\*\], HbA1c 5.2%+ \[OR 1.949\*, 95% CI 1.047-3.629\*\] , LDL-C 120 mg/dL+ \[OR 1.380\*\*, 95% CI 1.073-1.781\*\*\], ALT 31 IU/l+ \[OR 1.585\*, 1.396\*\*\*/ 95% CI 1.159-2.168\*, 1.109-1.757\*\*\*\], gamma-GTP 50 IU/l+ \[OR 1.555\*\*, 95% CI 1.082-2.235\*\*\] and systolic blood pressure 130 mmHg+ \[OR 1.301\*\*\*, 95% CI 1.034-1.636\*\*\*\]. **Conclusion:** The proposed study demonstrates the association of AGA with obesity, HbA1c, LDL-C, ALT, gamma-GTP and systolic blood pressure in Japanese males.

A023: Hair Menace

Maya Vincent\*, Krishnan Yogiraj

Dr. K. Yogiraj Centre for Dermatology and Venereology, Trivandrum, Kerala, India

Presenting a rare case of incarcerated hair causing hair granuloma in a 65-year-old male who had used a wig for more than 20 years. The lesions manifested after he stopped using the wig, and were seen only on the bald pate. Lesions resolved completely with topical treatment.

A024: Nanocarriers for hair follicle targeting: How different skin penetration properties of nanocarriers open new perspectives.

Annika Vogt^1\*^, Fiorenza Rancan^1^, Behazine Combadiere^2^, Bernard Verrier^3^, Ulrike Blume-Peytavi^1^

^1^Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, ^2^Laboratoire d′Immunologie Cellulaire, Université Pierre et Marie Curie, INSERM U543, Paris, France, ^3^Institut de Biologie et Chimie des Protéines, UMR 5086 CNRS, Lyon Cedex 07, France

Following our concept of using nanocarriers for dendritic cell targeting in human skin, we studied skin penetration and drug delivery properties of solid engineered particles, biodegradable polymer particles, viruses and virus-like particles. For all particle types, we demonstrated that hair follicles are sites for intensive interactions with the epithelium and associated cell populations. Penetration and antigen release, however, differed significantly among the carrier systems. Engineered, solid gold, silica and polystyrene particles with sizes up to 200nm did not penetrate across intact stratum corneum, but hair follicle penetration and cellular uptake was observed especially, when hair follicle penetration was enhanced by cyanoacrylate skin surface stripping. Biodegradable polymer particles, produced with the intention to overcome hazardous effects related to translocation of nanomaterials into the organism, lost their supramolecular organization upon skin contact and released incorporated fluorescent dyes both, on the skin surface and in the hair follicle canals. Stability was enhanced by coating with antigenic peptides, e.g. HIV-1p24, in a way that release of free peptide occurred predominantly in the hair follicle ducts. Virus-like particles carrying the same HIV-1p24 peptide were found to be associated prevalently with CD1a-positive Langerhans cells after topical application on skin explants. Our results demonstrate that the different particle types display very different penetration and drug release properties which make them attractive for very different therapeutic approaches. E.g. delivery of particle-associated antigen rather than free peptides is crucial for transcutaneous vaccination purposes, while delivery of free peptides to the hair follicle may open new perspectives for hair therapy.

A025: Correction of Th1-Th2 Imbalance is the Mode of Action in Treatment of Alopecia Areata with DPCP Topical Immunotherapy

Yugang Gong, Ying Zhao, Xiaoting Zhang, Yanting Ye, Zeming Cai, Bin Zhang, Sillani Caulloo, Jian Yang, Wenna Chen, \*Xingqi Zhang

Department of Dermatology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, People\'s Republic of China

**Objective:** To investigate the therapeutic effect and to explore the mechanism of topical immunotherapy with Diphenylcyclopropenone (DPCP) in AA patients. **Methods**: A total of 80 patients with severe AA were treated with DPCP, and data collected at time of pre- and post-treatment. Serum cytokine levels were measured in 13 healthy controls and 21 patients pre- and post-treatment using ELISA. Semi-quantitative real-time PCR was also performed to detect local cytokine profile. **Results:** The responsive rate to DPCP with satisfactory hair regrowth was 58.5%. Pre-treatment serum IgE level was higher in adverse-effects group than in responder group. Alopecic patients had a remarkably higher serum level of Th1 cytokine such as IFN-γ, IL-12 when compared to healthy controls. Post-treatment levels of IFN-γ, IL-12 were significantly decreased, but levels of IL-4, IL-10 were increased in responder group, which was different from the non-responder group. Increased IL-5, IL-17 levels were found both in responder and non-responder groups when compared to pre-treatment levels as well as to controls. Lesional cytokine profile detected by QRT-PCR was in concordance with serum results in general. No statistical significance was found on comparison of IL-18, IL-22 to the control group. **Conclusions:** Topical immunotherapy treatment is an effective way to treat severe AA patients and it is relatively safe. Mechanism of action may involve restoration of the Th1-Th2 imbalance by decreasing Th1 cytokine levels and increasing Th2 cytokine levels. The newly formed cytokine milieu is crucial to promote entry of hair follicles into anagen stage and hair regrowth.

A026: Hair Follicle Homeostasis Impairment in Alopecia Areata

Aida Gadzhigoroeva, Eugenia Kogan

Department of Pathomorphology, 1^st^ Moscow State Medical University, "Clinic of Danishchuk", Moscow, Russia

Alopecia areata (AA) is a recurrent non-scarring type of hair loss that can affect any hair-bearing area with autoimmune pathogenesis, when hair follicles (HF) lose immune tolerance. **Aim:** To investigate tissue homeostasis in HF in AA based on pathologic process activity. **Materials and Methods:** Skin biopsies of 44 patients with AA of different activity. 20 specimens were taken from "zone of shattered hair" (acute form) and 24 with total (chronic) form. As control, 6 specimens of skin from scalp were taken during cosmetic surgery. Paraffin slides were made with following morphological and immunohistochemical analysis (IHA). Primary antibodies of CD4+, CD8+, CD68+; CD95, FasL(LabVision), Ki67+, bcl2, CK15+ (DAKO). Apoptosis was assessed using in situ labeling TUNEL System (Promega). **Results:** IHA showed that perifollicular and perivascular infiltrates in acute AA are prominent and consist of CD8+, CD4+ T-lymphocytes, moderate amount of macrophages CD68+, and in chronic AA are moderate and have decrease in amount of CD8+ and moderate increase in CD4+ and CD68+ cells, with relative CD68+ cells predominance (*P*\<0.01). Apoptosis was high in epithelial cells of the outer epithelial sheath of the hair root (OESHR): in bulge and in lower part of HF (33% and 0.1% in control). Keratinocytes expressed Fas/Apo-receptors in the same zone (90% and 5% in control), and inflammatory infiltrate cells expressed FasL in ΡD8+ and CD68+cells (30% and 0% in control). In chronic AA, apoptosis was low, few cells expressed FasL and Fas+ (1% and 24%, respectively). Bcl2+cells were found in control (28% epithelial cells). Acute form lack bcl2+, Ki67+ epithelial cells were low 5% (15% in control), ΡK15+ cells were found in HF zone (25% in HF). Chronic form showed Ki67+ cells in 10% of epithelium; bcl2+ was found in dermal papilla (17% of cells), CK15+ cells were found in outer layer epithelium in bulge zone, and in few cells near these zones but in lower values than control (15% and 25%, respectively). **Conclusion:** The morphological pattern of AA has features caused by acute inflammation and the duration of the pathological process. In the acute stage, inflammation leads to disruption of tissue homeostasis and results in hair follicle dysmorphogenesis, that is based on apoptosis activation in its parts. In the chronic stage repair processes occur: partial regeneration of the epithelium in OESHR is accompanied by the appearance in the area of ​​bulge CK15+ cells that migrate through the area of hair papilla, showing that they may participate in HF recovery. The area pluripotent stem cells of bulge zone or zone of the HF papilla may be considered as a source of recovery, where bcl2+ cells are observed in the chronic stage of AA, which may indicate a genetic mechanism for maintaining a pool of hair follicle cells progenitor cells.

A027: Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Severe Type of Alopecia Areata

Seung Hwan Paik^1^, Seungbok Lee^2,3^, Hyun-Jin Kim^2,3^, Hyeong Ho Ryu^1^, So-eun Cha^2^, Seong Jin Jo^1^, Hee Chul Eun^1,5,6^, Jeong-Sun Seo^2,3,4^, Jong-Il Kim^2,3,4^, Oh Sang Kwon^1,5^

^1^Department of Dermatology, Seoul National University College of Medicine, ^2^Genomic Medicine Institute (GMI), Medical Research Center, Seoul National University, ^3^Department of Biomedical Sciences, Seoul National University Graduate School, ^4^Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, ^5^Laboratory of Cutaneous Aging and Hair Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea

Alopecia areata (AA) is a common autoimmune disorder mostly presenting as round patches of hair loss and sub-classified into alopecia totalis/alopecia universalis (AT/AU) based on the affected area of alopecia. Although AA is relatively common, AT/AU is exceptionally rare, as only 5% of AA patients were reported to progress into AT/AU. To determine functional genetic determinants of this orphan subtypes of the disease, we undertook exome-wide association study using 6 samples from AU patients, which were compared with 155 normal Asian controls. Our study revealed the statistically significant 27 immune-related candidate genetic variants (*P*\<0.05) and in the replication study with independent 14 AU samples, 8 out of them were replicated (*P*\<0.05). Interestingly, the linkage disequilibrium was observed between some of the most significant SNPs, which were rs41559420 of HLA-DRB5, rs28362679 of BTNL2, and rs41542812/rs1049107 of HLA-DQB1. Among these three genes, HLA-DQB1 and BTNL2 were previously reported as general susceptibility genes of AA, but HLA-DRB5 has not been implicated in AA. In addition, we also replicated other two genes associated with AA (C5, HLA-A) at the gene level and found novel genetic variants of AA (HLA-DMB, LTF, TLR1, PMS2 and DMBT1). This study provides additional evidences for association of previously reported immune-related genes with AA and novel findings such as HLA-DRB5 implicated in AU, which might represent a hidden culprit gene of the disease development.

A028: Efficacy and Tolerability of Medium-dose Oral Prednisolone Pulse Therapy Over 4 to 8 Weeks in Alopecia Areata

Anja Miesel, Detlef Zillikens, Tobias W. Fischer^\*^

Department of Dermatology, Allergology and Venereology, University of Lübeck, Lübeck, Germany

Alopecia areata (AA) is a common disease with limited effective therapeutic options, so identification of a stage-adapted, effective, safe, pragmatic and time-saving therapy is still needed.

A monocenter retrospective, clinical outcome study of oral medium-dose prednisolone pulse therapy was performed in 36 patients (37 treatments; mean age 42 years; 26 female, 10 male) with active AA (23 AA multilocularis, 13 AA of different type). A continuous, specific therapy scheme was defined over 4 weeks starting with 50 mg prednisolone per day descending to 10 mg daily. Upon positive response after 4 weeks, continuation up to a total of 8 weeks with two weeks 20 mg and 10 mg per day, respectively, was performed. Negativation of pull-test and hair re-growth were defined response criteria.

After 4 weeks, the pull-test turned negative in 46.2% and after 8 weeks even in 62.5% of treated patients. Hair re-growth was observed in 63.9% after 4 and in 87.5% after 8 weeks. About 90% of the patients showed no (62.2%) or gentle to slight (27%) side effects (sweating, slight body weight or blood pressure increase, stomach acidity, acne) while moderate side effects (itching, weakness) occurred in 5.4%. One patient showed severe side effects (vomiting, hot flush, sleep disturbance), however, all side effects resolved after therapy end.

In conclusion, the presented protocol of oral medium-dose prednisolone pulse therapy of up to 8 weeks is a successful therapy with high responding rates and relatively small side effects and therefore represents an effective, safe and time-saving option in AA patients.

A029: The Development of Alopecia Areata may Result in Abnormal Remodeling and Fibrosis of the Heart

Eddy H.C. Wang\*, Katy Chong, David Granville^1^, Jerry Shapiro^2^, Kevin J. McElwee

Department of Dermatology and Skin Science, University of British Columbia, ^1^The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul\'s Hospital, University of British Columbia, ^2^Department of Dermatology and Skin Science, Vancouver General Hospital, Vancouver, BC, Canada

Alopecia areata (AA), an inflammatory, non-scarring hair loss disease is believed to involve an autoimmune mechanism. Psoriasis, also an autoimmune skin condition, has increased cardiovascular disease comorbidity. We investigated the potential for a relationship between AA and heart disease. It was noted that some of the C3H/HeJ mice with AA had enlarged atria and ventricular hypertrophy compared to normal haired littermates. Significant increase in the gene expression of IL18 (4.6 fold), IL18 receptor-1 (IL18r1, 2.8 fold) and IL18 binding protein (IL18bp, 5.2 fold) was observed in AA heart tissue compared to controls using quantitative PCR (qPCR). Significant increase of IL18r1, IL18bp and Interleukin Converting Enzyme (ICE) were observed 10 weeks post skin graft in a time course study. Significant increased peri-vascular collagen within the hearts of AA mice was revealed by Masson\'s Trichrome Stain, an indication of fibrosis. Furthermore, the thickness of the blood vessels′ endothelial layer was significantly thinner. Immunohistochemistry analysis showed a localization of IL18 in the atria of AA mice that resembles the phenotype of atrial fibrillation. In an atria tissue organ culture assay, adrenocorticotropic hormone (ACTH) induced the expression of IL18 and releases of cardiac troponin I (cTnI) in both AA and control mouse atria. ACTH has previously been found to be elevated in AA affected mice; such dysregulated stress hormones may have adverse impact on the health of the heart.

A030: Comparison of Changes in Serum Cytokine Levels Before and After Hair Loss in Alopecia Areata Induced C3H/Hej Mice - Preliminary Study

Chan Yil Bang, Hee Jin Song, Jung Hyun Shin,

Gwang Seung Choi \*

Department of Dermatology, College of Medicine, Inha University, Incheon, Korea

**Background:** Although the etiopathogenesis of alopecia areata is poorly understood, several studies have shown that cytokines and other molecules that coordinate cyclical hair growth play a crucial role. The possible relationship between T helper 1 cell-mediated autoimmune response against hair follicle and alopecia areata has been proposed. Many researches investigated to measure cytokine levels both in sera and tissues after the development of alopecia areata was compared with the normal control group. However, no previous study was done comparing serum cytokine levels before and after the development of alopecia areata, because it is difficult to obtain enough blood samples from C3H/HeJ mouse to measure the serum cytokine levels using ELISA. C3H/HeJ mouse is a commonly used animal model for alopecia areata. **Objectives:** The authors seek to measure the difference in cytokine levels before and after alopecia areata by inducing alopecia in C3H/HeJ mice. **Methods:** We used 46-week-old C3H/HeJ mice with whole body hair loss as a donor and skin graft was done from this mouse to six C3H/HeJ mice of 6-week-old. We obtained blood samples from six C3H/HeJ recipient mice before full thickness skin graft and one week after the development of alopecia areata, blood samples were obtained again and we compared cytokine levels before and after the development of alopecia areata. We used quanti-body array kit which can measure serum cytokine levels from only small amount of blood sample. Using this kit, we compared the serum cytokine levels in C3H/HeJ mice before and after the development of alopecia areata. **Results:** The levels of IFN-γ, IL-12, IL-2 and 1L-13 were increased after the development of alopecia areata and among them, increase of IFN-γ showed statistical significance. The levels of IL-4 and IL-1α were decreased after the development of alopecia areata and showed statistical significance. There was no significant change in others. **Conclusion:** The authors suggest that probably T-helper 1 cytokine play an important role in the pathogenesis of alopecia areata.

A031: Diffuse Hair Loss in Women ߝ Rational Diagnostics and TherapeutIc Options

Gerhard Lutz

Hair & Nail, Bonn, Germany

Diffuse hair loss, especially in women, is always a challenge for every dermatologist. Possible causes and diseases which induce and imitate diffuse hair loss can be very different, e.g. dermatological and internal diseases, endocrinological disorders, deficiency of iron, zinc or biotin, side effects of drugs, hair damage through cosmetic procedures etc. What evidence-based diagnostics and relevant serological parameters should be taken into consideration to solve this problem?

As only therapeutic options specific to the diagnosed disorders are the key to success, a structured proceeding is absolutely necessary.

The anamnesis should include beginning, duration and a hereditary disposition as well as possible seasonal variations of hair loss. To exclude drug-induced hair loss, all actual medicine and that taken in the last 4 months have to be proofed for disturbing hair growth. In most cases only scalp hair is involved. Typical is a diffuse shedding of the scalp hair in the central and parietal areas. Endocrinological diagnostics should include basal TSH, Prolactin, FSH, Estradiol, Testosterone and Androstenedione. Because androgenetic alopecia in women can also start and exist by a diffuse shedding of the hair, the mentioned gynecological parameters should be estimated in the follicular phase of the menstrual cycle. In case of oral contraceptives controlling should take place at the end of the monthly pill pause. The presentation summarizes 20 years of experience in the management of diffuse hair loss in women and discusses the relevance of diagnostic results for therapeutic strategies, supplemented by clinical pictures.

A032: Temporal Hair Growth Characteristics and Biodisposition of Bimatoprost in Skin

David Frederick Woodward, Jenny Weizhen Wang, Elaine Shih-Huey Tang, Mayssa Attar^1^

Departments of Biological Sciences and ^1^Pharmacokinetics and Drug Biodisposition, Allergan Inc., Irvine, CA, USA

Bimatoprost is used to treat eyelash hypotrichosis and pharmaco-cosmetically for enhancing eyelash appearance. It is currently under clinical investigation for treating male pattern baldness. Bimatoprost biodisposition in the skin has not been investigated to date, although its metabolic fate has been extensively characterized. Hair growth was studied on pelage skin in C57/Bl6 mice. Daily topical application of graded doses of bimatoprost to the backs of shaved mice significantly reduced the time of onset for hair growth. Moreover, the time to achieve complete hair regrowth was greatly reduced. Analysis of 0.03% bimatoprost biodisposition in the skin after one and twenty one days of treatment in mice revealed concentrations of 1.33 and 3.61 μg/g tissue, respectively . Bimatoprost was detected only as the intact molecule, no conversion to 17-phenyl PGF~2α~ was apparent. Bimatoprost (intact) was detected in the blood: 1 day treatment = 1.83 ng/ml, 21 day treatment = 1.56 ng/ml. These data demonstrate that the effect of bimatoprost on hair growth involves only the intact molecule, likely interacting with prostamide receptors. Bimatoprost biodisposition was also investigated in pig and human skin. In a 14-day study in mini-pig skin, 0.03% bimatoprost resulted in a skin level of 12.5 μg/g tissue. This was much higher than observed in mouse skin. In mini-pig skin a small amount of 17-phenyl PGF ~2α~ was detected (30.8 ng/g tissue). Extended treatment protocols with higher doses produced similar results. Hair growth was not studied in mini-pigs. Studies in isolated human skin specimens, using the Franz chamber, revealed that the highest proportion of bimatoprost in the tissue were associated with the epidermis. Less than 0.06% of bimatoprost was recovered as 17-phenyl-PGF~2α~.

A033: Innovating Custom Cut Blades in Hair Transplantation

Lourdhurajan Renita

Consultant Dermatologist, Chennai Skin Hair Nail Clinic, Chennai, Tamil Nadu, India

Hair transplantation techniques have undergone multiple revisions over time, in order to improve the outcome, aesthesis, ergonomics, while decreasing adverse effects. The making of the recipient site is crucial to achieving the desired density, while maximizing graft survival. The Nokor needle is widely used, however, custom-cut blades are also being used in many clinics. The razor blade (traditional model with 2 cutting edges) is used in dermatosurgery, for shave excision, ultrathin graft harvesting, and in superficial biopsies. We have found yet another use of the razor blade, in creating recipient sites in hair transplantation. It has the advantage of custom-cut blades, in providing a cylindrical recipient site, but is significantly thinner. Also, being so thin, it can be easily cut into longitudinal bits with a pair of scissors, thereby obviating the need for expensive blade cutting instruments. Further, postoperative healing is more aesthetic, without any boggy feel/appearance. Again, due to its near single dimension, dense packing of grafts is made easy. Once cut to the required size, the blade bit can be held by a needle holder, the length of the blade adjusted to the exact depth of the recipient site as determined by the length of the graft. Further, the razor blade can also be used in graft dissection.

In conclusion, the versatile razor blade has much to offer in hair transplantation while significantly reducing the instrument costs, at less than Rs 1/blade. Further, use of the razor blade in creating the razor blade can also be used in graft dissection.

In conclusion, the versatile razor blade has much to offer in hair transplantation while significantly reducing the instrument costs, at less than Rs 1/blade. Further, use of the razor blade in creating recipient sites helps improve the cosmesis.

A034: Human Scalp Hair Follicles Express PGF

2α

Lipid Mediator and the Enzymes to Synthesise

De Novo

Prostaglandins and Prostamides

Karzan G. Khidhir^\*^, Nilofer P. Farjo^1^, Bessam K. Farjo^1^, David F. Woodward^2^, Steven M. Picksley, Valerie A. Randall

Centre for Skin Sciences, University of Bradford, Bradford, United Kingdom, ^1^Farjo Medical Centre, Manchester, United Kingdom and ^2^Allergan Inc, Irvine, CA, USA

Prostaglandin F~2α~ (PGF~2α~) analogues e.g. latanoprost and a prostamide F~2α~ analogue, bimatoprost, used for treating glaucoma stimulates eyelash growth as a side effect. The mechanism of action by which these drugs stimulate eyelash hair growth is poorly understood, but we have recently shown receptors for PGF~2α~ (FP) and prostamide F~2α~ in scalp hair follicles. This suggests that both PGF~2α~ and prostamide F~2α~ may play role in the hair follicle. To determine whether PGF~2α~ lipid mediator and the enzymes to synthesize prostaglandins and prostamides *de novo* from phospholipids are expressed in human scalp hair follicles, electrospray tandem mass spectrometry coupled to liquid chromatography (LC/ESI-MS/MS), RT-PCR and qPCR were carried out. Scalp hair follicles were individually microdissected for RNA extraction from non-balding scalp skin from 8 men undergoing elective cosmetic surgery with appropriate approval. Isolated scalp hair follicle expressed PGF~2α~ lipid mediator, 13.39 ± 1.8 pg/mg of follicle protein (mean ± SEM, n=3) and the enzymes to synthesize *de novo* prostaglandins and prostamides from phospholipids: PLA ~2~ , COX-1, COX-2, FAAH ~1~ and FAAH ~2~ (n=5). Thus, isolated human scalp follicles contain PGF~2α~ lipid mediator and express the enzymes to synthesize prostaglandins and prostamides *de novo* which would enable the local synthesis of these prostanoid and prostamide mediators from phospholipids. Further metabolism of many prostaglandins and receptors for prostaglandins have previously been reported by Colombe et al, 2007 & 2008 and more analysis of the actual roles of these paracrine mediators in hair follicle may lead to a new approach for alopecia treatment.

A035: Clinical Comparison of Two Popular Hair Reduction Lasers in Asian Skin, on Fine Hair

Ameet Dandale, Rachita Dhurat

Department of Dermatology, LTMMC & GH, Sion, Mumbai, India

**Introduction:** Studies comparing efficacy of different lasers on reduction of fine hair are rare. In our study we attempted to compare two popular laser systems - ′in-motion Diode\" and Q-switched Nd-YAG, in terms of efficacy and safety for reduction of fine hair on Indian skin. **Materials and methods:** In a prospective comparison study, total of 23 females with hair type IV were enrolled and subjected to Q-switched Nd-YAG on left side and in-motion diode laser on right side of the selected body parts. The patients received 4 sessions spaced at 4-6 weeks interval. Results were evaluated with a diagnostic camera system specifically designed for hair counts and diameter. **Results:** At 3 months after the 4th session, it was found that more than 50% of hair reduction was retained in 43%, 50%, and 17% of volunteers with in-motion diode, whereas more than 50% hair reduction was noted in 14%, 0% and 33% with Q-switched Nd-YAG, respectively, on forearms, side locks and upper lips. **Conclusion:** In motion, diode is an effective and painless means of achieving hair reduction in fine hair on skin types IV-V. Q-switched Nd-YAG gives a good delay of growth but is not effective for long-term hair reduction.

A036: Randomised Evaluator Blinded Study of Efficacy of Microneedling on Androgenetic Alopecia: A Pilot Study

Rachita Dhurat^\*^, Ganesh Avhad, Ameet Dandale, Sukesh MS, Kunal Bhandari

Department of Dermatology, L.T.M. Medical College and General Hospital, Sion, Mumbai-400 022, Maharashtra, India.

**Introduction:** Minoxidil and finasteride have been approved for androgenetic alopecia in male. There is other non-approved treatment, efficacy of which is not well studied. Microneedling is one of the alternative therapeutic options. Microneedling works by stimulation of stem cells and inducing activation of growth factors. **Materials and Methods:** Ten clinically diagnosed cases of androgenetic alopecia grade III/IV were recruited into 2 groups. One group was offered weekly microneedling treatment with twice daily 5% minoxidil (treatment group) foam application; other group was given only 5% minoxidil application (control group). After baseline global photographs, the scalp were shaved off to ensure equal length of hair shaft in all. Hair count was done in 1 cm^2^targeted fixed area (marked with tattoo) at baseline and at end of therapy (week 12). Two blinded investigators evaluated global photographic response. The response was assessed by seven-point scale. **Results:** The mean hair count significantly increased from 226 to 317 in treatment group while control group had shown marginal increase from 196 to 218. On seven-point scale, 4/5 patients had +2 and +3 responses in treatment group, 3/5 had +1 response and 2/5 had no change in control group. At the end of 12 weeks, treatment group had shown good response (p value: 0.039) versus control group. Intraclass correlation between two blinded investigators was 100%. **Conclusion:** Combination of microneedling + 5% minoxidil foam daily acts synergistically and the response was fasten. So microneedling is new horizon in armamentarium in treatment of alopecia.

A037: Restoration of hair-inductive activity by sphere formation is unique to dermal papilla cells and is not applicable to dermal sheath cells

Gong Hee Won, Moon Kyu Kim, Jung Chul Kim, Young Kwan Sung\*

Department of Immunology, School of Medicine, Kyungpook National University, Daegu, Korea

Use of three-dimensional (3D) spheroid cultures can result in restoration of hair-inductive activity of two-dimensional (2D) cultured dermal papilla (DP) cells. These findings raise the question of whether restoration of hair-inductive activity (trichogenicity) by sphere formation is unique to DP cells or can be applied to other adult human dermal cells, including dermal sheath (DS) cells. Here, we compared DS spheres with DP spheres in terms of expression of genes implicated in hair follicle trichogenicity and neogenesis. Results of immunofluorescence staining showed that expression of versican, which has been reported to show correlation with the hair-inducing capacity of mouse DP cells, was fully restored in DP and DS spheres. However, alkaline phosphatase activity, which has also been reported to show correlation with the hair-inducing capacity of dermal cells, was fully restored in DP spheres, but only partially restored in DS spheres. Implantation of DP spheres resulted in induction of hair follicles in 14 of 22 cases (63%), whereas no hair follicles were observed in 16 cases of implantation of DS spheres. DiI-labeled cells of DP spheres were observed in DP of induced new hair follicles, whereas DiI-labeled cells of DS spheres were scattered throughout the grafted dermis. Results of microarray analysis showed differential gene expression between DP spheres and DS spheres. Data from this study demonstrate that restoration of trichogenicity by sphere formation is unique to DP cells and is not applicable to other adult dermal cells, possibly due to differential expression of genes that contribute to trichogenicity.

A038: Novel target genes of caffeine in male and female human hair follicles

Tobias W. Fischer^1\*^, Tamas Biro^2^, Nathalie Kruse^1^, Detlef Zillikens^1^, Ralf Paus^1,3^

^1^Department of Dermatology, Allergology and Venereology, University of Lübeck, Lübeck, Germany,^2^Department of Physiology, University of Debrecen, Debrecen, Hungary,^3^School of Translational Medicine, University of Manchester, Manchester, U.K.

The xanthine derivative, caffeine, has been shown to stimulate human hair growth *in vitro*. Besides the phospho-diesterase inhibitory effects, very little about additional bioregulatory effects is known. Therefore, a genome-wide gene analysis to identify new target genes and pathways of caffeine in human hair follicles (HFs) was performed. HFs from 6 men and 6 women with androgenetic alopecia were acquired by elective scalp skin biopsies, cultivated for up to 120 h *in vitro* with caffeine or vehicle, and subjected to microarray analysis. While multiple genes were regulated by caffeine, significant

(*P*\<0.05), two- or more-fold regulation in the same direction in at least 4 to 5 out of six individuals was observed in 19 (male HF) and 22 (female HF) genes. The most profoundly caffeine-regulated genes were Dermicidin (DCD), 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), lactotransferrin (LTF) and L-kynurenine hydrolase (KYNU). Quantitative RT-PCR confirmed DCD up-regulation in all samples, whereas LTF was only confirmed in male HFs, while PFKFB3 was confirmed in female HFs. Immunofluorescence-confirmed in situ protein expression of DCD, LTF, and PFKFB3 at specific anatomic sites of the HF, and protein up- or down-regulation mostly corresponded to the respective gene regulation. Additional pathway analysis revealed that classical hair growth controls (e.g. TGFβ-, Wnt-, Notch-, insulin-, metabolism and proliferation signaling pathways) are also caffeine-regulated.

In conclusion, this gene profiling study together with analysis of relevant protein expression patterns in human HFs in situ represents an important basis for the development of new hair growth-modulatory agents that employ caffeine as a lead substance.

A039: Human scalp hair follicles express PGF

2α

lipid mediator and the enzymes to synthesise

de novo

prostaglandins and prostamides

Karzan G. Khidhir^\*^, Nilofer P. Farjo^1^, Bessam K. Farjo^1^, David F. Woodward^2^, Steven M. Picksley, Valerie A. Randall

Centre for Skin Sciences, University of Bradford, Bradford, United Kingdom,^1^Farjo Medical Centre, Manchester, United Kingdom and^2^Allergan Inc, Irvine, CA, USA

Prostaglandin F~2α~ (PGF~2α~) analogues e.g. latanoprost and a prostamide F~2α~ analogue, bimatoprost, used for treating glaucoma stimulates eyelash growth as a side effect. The mechanism of action by which these drugs stimulate eyelash hair growth is poorly understood, but we have recently shown receptors for PGF~2α~ (FP) and prostamide F~2α~ in scalp hair follicles. This suggests that both PGF~2α~ and prostamide F~2α~ may play role in the hair follicle. To determine whether PGF~2α~ lipid mediator and the enzymes to synthesize prostaglandins and prostamides *de novo* from phospholipids are expressed in human scalp hair follicles, electrospray tandem mass spectrometry coupled to liquid chromatography (LC/ESI-MS/MS), RT-PCR and qPCR were carried out. Scalp hair follicles were individually microdissected for RNA extraction from non-balding scalp skin from 8 men undergoing elective cosmetic surgery with appropriate approval.

Isolated scalp hair follicle expressed PGF~2α~ lipid mediator, 13.39±1.8 pg/mg of follicle protein (mean±SEM, n=3) and the enzymes to synthesize *de novo* prostaglandins and prostamides from phospholipids: PLA ~2~ , COX-1, COX-2, FAAH ~1~ and FAAH ~2~ (n=5).

Thus, isolated human scalp follicles contain PGF~2α~ lipid mediator and express the enzymes to synthesize prostaglandins and prostamides *de novo* which would enable the local synthesis of these prostanoid and prostamide mediators from phospholipids. Further metabolism of many prostaglandins and receptors for prostaglandins have previously been reported by Colombe et al, 2007 and 2008, and more analysis of the actual roles of these paracrine mediators in hair follicle may lead to a new approach for alopecia treatment.

A040: Non-Scarring Hair Loss in Patients with System Lupus Erythematosus is Associated with Skin Discoid Rash, Anti-Rnp and Local Angiotelectasis

Yanting Ye, Ying Zhao, Yugang Gong, Xiaoting Zhang, Sillani Caulloo, Bin Zhang, Zeming Cai, Jian Yang, Xingqi Zhang\*

Department of Dermatology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, People\'s Republic of China

**Objective:** To understand the circumstance surrounding non-scarring hair loss in systemic lupus erythematosus (SLE), in regards to clinical and histopathological characteristics of this entity of alopecia. **Methods:** Clinical, dermoscopic and laboratory data from 49 SLE patients with non-scarring hair loss complaints (hair loss group) and 37 SLE patients without the complaints (non-hair loss group) were collected and analyzed. **Results:** Discoid rash and anti-RNP were more common in hair loss group than non-hair loss group (*P*\<0.05). Non-scarring alopecia in the hair loss group was divided into four patterns: diffuse effluvium (23/49, 46.9%), patchy alopecia (20/49, 40.8%), lupus hair (2/49, 4.1%) and combined types of hair loss (4/49, 8.2%). Main scalp dermoscopic signs in hair loss group included hypopigmentation and decrease in diameter of hair shaft, angiotelectasis, focal atrichia, scalp pigmentation, peripilar sign, follicular ostia dilation and increase of vellus hair. The perifollicular type and polymorphous presentation of angiotelectasis were found more common in the hair loss region of patients with SLE, whereas interfollicular arborizing pattern was observed more common in non-hair loss group. Perifollicular atypical red vessels in the hair loss region were related to a worse disease condition. Both patchy and diffuse types of hair loss in SLE were different from alopecia areata based on the dermoscopic findings and pathological changes. **Conclusion:** In patients with SLE, skin discoid rash and anti-RNP were positively correlated with alopecia. The findings of hypopigmentation, decrease in diameter of hair shaft and the location of angiotelectasis may shed lights on the unique mechanism of alopecia.

A041: Impact of Hair Loss on Quality of Life

D. Dinesh Kumar\*, Jayakar Thomas

Department of Dermatology, KK CHILDS Trust Hospital, Chennai, India

**Aim:** To study the impact of androgenetic alopecia (AGA) and alopecia areata (AA) on patients′ illness, behavior and quality of life (QOL). **Materials and Methods:** A total of 192 male patients with AGA and 86 patients with AA were enrolled and interviewed with structured questionnaire which contained 26 items including personal information, social, psychological questions and the patients' knowledge of his/her alopecia. **Result:** For AGA, the mean age of the patients was 27 years old. The proportion of patients under 30 years old was 79.7%. Most unmarried patients (89.3%) thought that hair loss would erode their chances for romance.

For AA, 14 patients were middle aged and 6 adolescents, sex incidence was equal. QOL was more impaired in adolescent age group, and in patients with extensive involvement, long duration and involvement of visible sites. The Dermatology Life Quality Index (DLQI) was impaired in the sample. (1) QoL was significantly poorer for women with alopecia, compared with men (2) Similarly, there were gender differences in several of the DLQI subscales (3) Women were significantly more likely to feel that alopecia affected their leisure activities and personal relationships (4) Men scored higher on work interference than women. **Conclusion:** This study specifically identifies the feelings of loss of self-confidence, low self-esteem and heightened self-consciousness in people affected by hair loss.

A042: Band-Like Scarring Alopecia in Erosive Pustular Dermatosis

Giselle Pinto

Erosive pustular dermatosis (EPD) is a rare cutaneous inflammatory disease with unknown etiology characterized by chronic sterile pustules, erosions, and crusted lesions, confined to the scalp with subsequent cicatricial alopecia.\[[@ref1]\] EPD may be preceded by local trauma, most often occurring in chronically actinic damaged scalp skin. Several reports show relation between skin grafting and EPD.\[[@ref2]\]

We report a case of EPD with a new clinical presentation: mixed pattern of ophiasis alopecia and frontal fibrosing alopecia (FFA).

A 50-year-old woman, smoker, presented with a 5-year history of crusted, draining, purulent plaques on her scalp which developed after partial thickness skin graft for squamous cell carcinoma.

On physical examination the scalp was covered by thickened serosanguineous scaly crusts with purulent exudates among the hairs. Erosive lesions were noted at the site of the skin graft leading to band-like ophiasis pattern of hair loss along the frontal, parietal and occipital scalp. Microbiological cultures were negative for bacterial and fungal growth. Series of scalp punch biopsies showed acanthosis, intrafollicular abscesses and focal loss of follicles replaced by follicular scars. There was dense diffuse inflammatory infiltrate through the entire dermis containing neutrophils, plasma cells and eosinophils. The clinical presentation of crusted, non-healing purulent erosions, the history of preceding skin graft and the histologic findings established the diagnosis of EPD. Topical therapy with corticosteroids under occlusion and doxycycline resulted in significant clinical improvement.

The condition of EPD is rare. Most published cases show pattern of patchy hair loss in parietal and occipital location or diffuse hair loss. The band-like ophiasis pattern shown here mimics frontal fibrosing alopecia. This unusual pattern of an uncommon disease may be the cause of delay in the diagnosis.

Eleftheriou LI, McIntee TJ, Stratman EJ. Aminolevulinic acid photodynamic therapy in the treatment of erosive pustular dermatosis of the scalp. Arch Dermatol 2011;147:1368-70Martins FJ, Herrera A, Rios JJ, Moreno JC, Camacho F. Erosive pustular dermatosis of the scalp after skin grafting. Dermatol Surg 2001;27:766-7.Allevato M, Clerc C, del Sel JM, Donatti L, Cabrera H, Juȥrez M. Erosive pustular dermatosis of the scalp. Int J Dermatol 2009;48:1213-6.

A043: Frontal Fibrosing Alopecia: An Evolving Clinical Entity

Archana Rao, Louise Fearfield

Department of Dermatology, Chelsea & Westminster Hospital, London, United Kingdom

A 30-year-old woman presented with a one year history of progressive hair loss affecting the frontal hairline and both eyebrows. No other hair bearing areas were affected. On examination she had erythema of the frontal hair line with evidence of follicular plugging. She also had considerable loss of hair from both eyebrows. Blood tests including a full blood count, thyroid function tests, iron profile, complement levels and anti-nuclear antibodies were unremarkable. A biopsy from inflamed scalp showed perifollicular inflammation, cytoid body formation and basal vacuolation with marked perifollicular fibrosis. The clinical and histological features were compatible with frontal fibrosing alopecia.

She became pregnant during the course of her treatment and therapy was deliberated at length. Management was discussed with the patient and she was treated with intralesional triamcinolone acetonide diluted to 5 mg/ml which kept the disease under control.

Frontal fibrosing alopecia was first described as recently as 1994 by Kossard. Initial studies showed the disease mainly affecting pre and postmenopausal women but studies thereafter have shown it affecting younger women and even men. Therapy remains a challenge with no convincing established treatment guidelines and more so in pregnancy which restricts treatment options even further. This is the first reported case addressing frontal fibrosing alopecia in pregnancy.
